Organon (OGN) Assets Average (2021 - 2026)
Organon (OGN) posted Assets Average of $13.1 billion for Q2 2026, up 1.2% on a QoQ basis from $12.9 billion in Q1 2026, and down 1.81% year-over-year from $13.3 billion in Q2 2025.
Analysis
Organon (OGN) Assets Average (2021 - 2026) Analysis & Trends
Organon has reported Assets Average for 6 years, with the latest figure at $13.1 billion in Q2 2026.
- On a quarterly basis, Assets Average fell 1.81% year-over-year to $13.1 billion in Q2 2026; TTM through Jun 2026 was $13.1 billion, a 1.81% decrease from a year earlier, with the FY2025 full-year figure at $13.0 billion, up 3.22% from the prior year.
- Assets Average was $13.1 billion for Q2 2026 at Organon, up from $12.9 billion in the prior quarter.
- The five-year high for Assets Average was $13.5 billion in Q3 2025, with the low at $10.5 billion in Q3 2022.
- Average Assets Average over 5 years is $12.0 billion, with a median of $12.0 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average decreased 5.36% in 2022, then climbed 13.26% in 2024.
- Over 5 years, Assets Average stood at $10.7 billion in 2022, then gained by 7.84% to $11.5 billion in 2023, then advanced by 12.06% to $12.9 billion in 2024, then gained by 2.19% to $13.2 billion in 2025, then decreased by 0.93% to $13.1 billion in 2026.
- The last three Assets Average figures came in at $13.1 billion (Q2 2026), $12.9 billion (Q1 2026), and $13.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 3.29 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 13.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.09 Bn |
| Mar 31, 2026 | 12.93 Bn |
| Dec 31, 2025 | 13.21 Bn |
| Sep 30, 2025 | 13.53 Bn |
| Jun 30, 2025 | 13.33 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 12.93 Bn |
| Sep 30, 2024 | 12.45 Bn |
| Jun 30, 2024 | 12.02 Bn |
| Mar 31, 2024 | 11.97 Bn |
| Dec 31, 2023 | 11.54 Bn |
| Sep 30, 2023 | 11.00 Bn |
| Jun 30, 2023 | 10.87 Bn |
| Mar 31, 2023 | 10.86 Bn |
| Dec 31, 2022 | 10.70 Bn |
| Sep 30, 2022 | 10.53 Bn |
| Jun 30, 2022 | 10.61 Bn |
| Mar 31, 2022 | 10.64 Bn |
| Dec 31, 2021 | 11.01 Bn |
| Sep 30, 2021 | 11.12 Bn |